These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 19954048)

  • 1. [The hazard and management strategies of human immunodeficiency virus and hepatitis C virus].
    Guo FP; Li TS
    Zhonghua Nei Ke Za Zhi; 2009 Aug; 48(8):617-9. PubMed ID: 19954048
    [No Abstract]   [Full Text] [Related]  

  • 2. Sustained disappearance of hepatitis C viremia in patients receiving protease inhibitor treatment for human immunodeficiency virus infection.
    Fialaire P; Payan C; Vitour D; Chennebault JM; Loison J; Pichard E; Lunel F
    J Infect Dis; 1999 Aug; 180(2):574-5. PubMed ID: 10395889
    [No Abstract]   [Full Text] [Related]  

  • 3. Septic bursitis, a potential complication of protease inhibitor use in hepatitis C virus.
    Burke CC; Martel-Laferriere V; Dieterich DT
    Clin Infect Dis; 2013 May; 56(10):1507-8. PubMed ID: 23413416
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV and hepatitis C coinfection.
    Matthews GV; Rockstroh J
    Curr Opin HIV AIDS; 2011 Nov; 6(6):449-50. PubMed ID: 22001889
    [No Abstract]   [Full Text] [Related]  

  • 5. [Coinfection of hepatitis C virus and human immunodeficiency virus and antiretroviral multitherapies].
    Zylberberg H; Pol S
    Gastroenterol Clin Biol; 1999; 23(8-9):878-81. PubMed ID: 10533139
    [No Abstract]   [Full Text] [Related]  

  • 6. Coinfection with hepatitis C virus and human immunodeficiency virus: virological, immunological, and clinical outcomes.
    Rotman Y; Liang TJ
    J Virol; 2009 Aug; 83(15):7366-74. PubMed ID: 19420073
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of the possible influence of hepatitis C virus and liver fibrosis on HIV type 1 immunological and virological outcomes.
    Collazos J; Cartón JA; Asensi V
    HIV Med; 2011 May; 12(5):308-15. PubMed ID: 20946441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viable strategies to facilitate liver transplantation for human immunodeficiency virus coinfection.
    Stock PG; Fung J
    Liver Transpl; 2009 Sep; 15(9):1003-6. PubMed ID: 19718639
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment for hepatitis C in patients infected with human immunodeficiency virus.
    Fernández I; Muñoz R; Solís-Herruzo JA
    Rev Esp Enferm Dig; 2003 Apr; 95(4):287-91, 282-6. PubMed ID: 12826005
    [No Abstract]   [Full Text] [Related]  

  • 10. Human immunodeficiency virus and hepatitis B and C coinfection: pathogenic interactions, natural history, and therapy.
    Kim AY; Chung RT; Polsky B
    AIDS Clin Rev; 2000-2001; ():263-306. PubMed ID: 10999223
    [No Abstract]   [Full Text] [Related]  

  • 11. Coinfection with human immunodeficiency virus and hepatitis C virus: challenges and therapeutic advances. Insights from the Society of Infectious Diseases Pharmacists.
    Deming P; McNicholl IR
    Pharmacotherapy; 2011 Apr; 31(4):357-68. PubMed ID: 21449625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of the effect of highly active antiretroviral therapy on hepatitis C virus (HCV) RNA levels in human immunodeficiency virus and HCV coinfection.
    Cooper CL; Cameron DW
    Clin Infect Dis; 2002 Oct; 35(7):873-9. PubMed ID: 12228825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The hepatitis C virus: after the track of the human immunodeficiency virus].
    Pérez-Olmeda M; Rodríguez-Rosado R; García-Samaniego J; Soriano V
    Rev Clin Esp; 1999 Jan; 199(1):5-7. PubMed ID: 10089769
    [No Abstract]   [Full Text] [Related]  

  • 14. Human immunodeficiency virus and the liver: lessons learned and still to be learned.
    Dieterich DT
    Semin Liver Dis; 2003 May; 23(2):107-14. PubMed ID: 12800064
    [No Abstract]   [Full Text] [Related]  

  • 15. Human immunodeficiency virus and hepatitis C virus: which is the cart, and which is the horse?
    Jenny-Avital ER
    Clin Infect Dis; 2003 Sep; 37(5):739; author reply 740. PubMed ID: 12942414
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapeutic aspects of human immunodeficiency virus, hepatitis B and C coinfection].
    Bani-Sadr F
    Gastroenterol Clin Biol; 2003 May; 27(5):528-33. PubMed ID: 12843917
    [No Abstract]   [Full Text] [Related]  

  • 17. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?
    Rodríguez-Torres M; Gonzalez-Garcia J; Bräu N; Solá R; Moreno S; Rockstroh J; Smaill F; Mendes-Correa MC; DePamphilis J; Torriani FJ;
    J Med Virol; 2007 Jun; 79(6):694-700. PubMed ID: 17457912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does fluvastatin favour HCV replication in vivo? A pilot study on HIV-HCV co-infected patients.
    Bader T
    J Viral Hepat; 2010 Mar; 17(3):227. PubMed ID: 19758277
    [No Abstract]   [Full Text] [Related]  

  • 19. Increase in hepatitis C virus load in hemophiliacs during treatment with highly active antiretroviral therapy.
    Ragni MV; Bontempo FA
    J Infect Dis; 1999 Dec; 180(6):2027-9. PubMed ID: 10558963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating hepatitis C virus in HIV patients: are side effects a real obstacle?
    Gatti F; Nasta P; Matti A; Manno D; Mendeni M; Puoti M; Carosi G
    AIDS Rev; 2007; 9(1):16-24. PubMed ID: 17474310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.